---
title: "Summit Therapeutics Insider Bought Shares Worth $9,999,983, According to a Recent SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262570910.md"
description: "Summit Therapeutics Insider Bought Shares Worth $9,999,983, According to a Recent SEC Filing"
datetime: "2025-10-24T08:25:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262570910.md)
  - [en](https://longbridge.com/en/news/262570910.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262570910.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262570910.md) | [繁體中文](https://longbridge.com/zh-HK/news/262570910.md)


# Summit Therapeutics Insider Bought Shares Worth $9,999,983, According to a Recent SEC Filing



### Related Stocks

- [Summit Therapeutics Inc. (SMMT.US)](https://longbridge.com/en/quote/SMMT.US.md)

## Related News & Research

- [Summit Networks delays annual 10-K filing](https://longbridge.com/en/news/281093737.md)
- [Here's How Much $1000 Invested In RTX 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/281237332.md)
- [Why EchoStar and Rocket Lab Stocks Could Be Top Buys Ahead of a SpaceX IPO](https://longbridge.com/en/news/281010490.md)
- [SpaceX could be the biggest IPO ever, potentially raising $40 billion to $48 billion: Eric Hippeau](https://longbridge.com/en/news/281219672.md)
- [Stock futures jump, oil prices retreat on report Trump willing to end war](https://longbridge.com/en/news/281105561.md)